1. Home
  2. KROS vs SBET Comparison

KROS vs SBET Comparison

Compare KROS & SBET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KROS
  • SBET
  • Stock Information
  • Founded
  • KROS 2015
  • SBET 1995
  • Country
  • KROS United States
  • SBET United States
  • Employees
  • KROS N/A
  • SBET N/A
  • Industry
  • KROS Biotechnology: Pharmaceutical Preparations
  • SBET Computer Software: Prepackaged Software
  • Sector
  • KROS Health Care
  • SBET Technology
  • Exchange
  • KROS Nasdaq
  • SBET Nasdaq
  • Market Cap
  • KROS 565.0M
  • SBET 618.0M
  • IPO Year
  • KROS 2020
  • SBET 1997
  • Fundamental
  • Price
  • KROS $15.65
  • SBET $16.12
  • Analyst Decision
  • KROS Buy
  • SBET
  • Analyst Count
  • KROS 14
  • SBET 0
  • Target Price
  • KROS $20.56
  • SBET N/A
  • AVG Volume (30 Days)
  • KROS 445.6K
  • SBET 36.3M
  • Earning Date
  • KROS 11-05-2025
  • SBET 08-14-2025
  • Dividend Yield
  • KROS N/A
  • SBET N/A
  • EPS Growth
  • KROS N/A
  • SBET N/A
  • EPS
  • KROS 0.47
  • SBET N/A
  • Revenue
  • KROS $232,844,000.00
  • SBET $3,144,153.00
  • Revenue This Year
  • KROS $5,579.44
  • SBET $858.54
  • Revenue Next Year
  • KROS N/A
  • SBET $194.83
  • P/E Ratio
  • KROS $33.59
  • SBET N/A
  • Revenue Growth
  • KROS 85820.30
  • SBET N/A
  • 52 Week Low
  • KROS $9.12
  • SBET $2.26
  • 52 Week High
  • KROS $72.37
  • SBET $124.12
  • Technical
  • Relative Strength Index (RSI)
  • KROS 59.98
  • SBET 41.93
  • Support Level
  • KROS $15.25
  • SBET $14.29
  • Resistance Level
  • KROS $16.00
  • SBET $20.27
  • Average True Range (ATR)
  • KROS 0.61
  • SBET 1.31
  • MACD
  • KROS 0.03
  • SBET -0.25
  • Stochastic Oscillator
  • KROS 78.77
  • SBET 26.63

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

About SBET SharpLink Gaming Ltd.

SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.

Share on Social Networks: